Literature DB >> 29362849

Insights into inflammatory priming of mesenchymal stromal cells: functional biological impacts.

Mehdi Najar1, Mohammad Krayem2, Makram Merimi3, Arsène Burny3, Nathalie Meuleman3, Dominique Bron3, Gordana Raicevic1, Laurence Lagneaux1.   

Abstract

Mesenchymal stromal cells (MSCs) are multipotent adult cells with relevant biological properties making them interesting tools for cell-based therapy. These cells have the ability to home to sites of injury and secrete bioactive factors as part of their therapeutic functions. However, depending on the local environment, diverse functions of MSCs can be modulated and thus can influence their therapeutic value. The specific cytokine milieu within the site of inflammation is vital in determining the fate and cell behaviors of MSCs. Indeed, inflammatory signals (called as inflammatory priming), may induce critical changes on the phenotype, multilineage potential, hematopoietic support and immunomodulatory capacity of MSCs. Thus, for appropriate clinical application of MSCs, it is important to well know and understand these effects. In summary, investigating MSC interactions with the inflammatory environment is necessary to empower the therapeutic value of MSCs.

Entities:  

Keywords:  Hematopoietic support; Immunomodulation; Inflammation; MSCs; Multilineage potential; Phenotype; Priming

Mesh:

Year:  2018        PMID: 29362849     DOI: 10.1007/s00011-018-1131-1

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  125 in total

1.  Morphological features of IFN-γ-stimulated mesenchymal stromal cells predict overall immunosuppressive capacity.

Authors:  Matthew W Klinker; Ross A Marklein; Jessica L Lo Surdo; Cheng-Hong Wei; Steven R Bauer
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-10       Impact factor: 11.205

2.  Mesenchymal Stem Cells Modulate Differentiation of Myeloid Progenitor Cells During Inflammation.

Authors:  Afsaneh Amouzegar; Sharad K Mittal; Anuradha Sahu; Srikant K Sahu; Sunil K Chauhan
Journal:  Stem Cells       Date:  2017-03-30       Impact factor: 6.277

Review 3.  Cytokines in acute and chronic inflammation.

Authors:  C A Feghali; T M Wright
Journal:  Front Biosci       Date:  1997-01-01

4.  Interleukin-1β induces differentiation of human mesenchymal stem cells into osteoblasts via the Wnt-5a/receptor tyrosine kinase-like orphan receptor 2 pathway.

Authors:  Koshiro Sonomoto; Kunihiro Yamaoka; Koichi Oshita; Shunsuke Fukuyo; Xiangmei Zhang; Kazuhisa Nakano; Yosuke Okada; Yoshiya Tanaka
Journal:  Arthritis Rheum       Date:  2012-10

5.  Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.

Authors:  Roland Meisel; Andree Zibert; Maurice Laryea; Ulrich Göbel; Walter Däubener; Dagmar Dilloo
Journal:  Blood       Date:  2004-03-04       Impact factor: 22.113

6.  Autocrine regulation of interferon gamma in mesenchymal stem cells plays a role in early osteoblastogenesis.

Authors:  Gustavo Duque; Dao Chao Huang; Michael Macoritto; Daniel Rivas; Xian Fang Yang; Louis Georges Ste-Marie; Richard Kremer
Journal:  Stem Cells       Date:  2009-03       Impact factor: 6.277

7.  IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells.

Authors:  Karen English; Frank P Barry; Ciara P Field-Corbett; Bernard P Mahon
Journal:  Immunol Lett       Date:  2007-04-26       Impact factor: 3.685

8.  Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC.

Authors:  Ralf Hass; Cornelia Kasper; Stefanie Böhm; Roland Jacobs
Journal:  Cell Commun Signal       Date:  2011-05-14       Impact factor: 5.712

9.  Interferon γ induced compositional changes in human bone marrow derived mesenchymal stem/stromal cells.

Authors:  Qingdong Guan; Peyman Ezzati; Victor Spicer; Oleg Krokhin; Donna Wall; John A Wilkins
Journal:  Clin Proteomics       Date:  2017-07-06       Impact factor: 3.988

10.  Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment.

Authors:  Olaia Naveiras; Valentina Nardi; Pamela L Wenzel; Peter V Hauschka; Frederic Fahey; George Q Daley
Journal:  Nature       Date:  2009-06-10       Impact factor: 49.962

View more
  25 in total

Review 1.  Modifying MSC Phenotype to Facilitate Bone Healing: Biological Approaches.

Authors:  Stuart B Goodman; Tzuhua Lin
Journal:  Front Bioeng Biotechnol       Date:  2020-06-24

Review 2.  Mesenchymal Stem Cells and Atopic Dermatitis: A Review.

Authors:  Sérgio Ricardo Teixeira Daltro; Cássio Santana Meira; Ivanilson Pimenta Santos; Ricardo Ribeiro Dos Santos; Milena Botelho Pereira Soares
Journal:  Front Cell Dev Biol       Date:  2020-05-14

3.  Tenogenic Properties of Mesenchymal Progenitor Cells Are Compromised in an Inflammatory Environment.

Authors:  Luisa Brandt; Susanna Schubert; Patrick Scheibe; Walter Brehm; Jan Franzen; Claudia Gross; Janina Burk
Journal:  Int J Mol Sci       Date:  2018-08-28       Impact factor: 5.923

4.  Mesenchymal Stem Cell Therapy for Aging Frailty.

Authors:  Ivonne Hernandez Schulman; Wayne Balkan; Joshua M Hare
Journal:  Front Nutr       Date:  2018-11-15

5.  Simulated microgravity modulates the mesenchymal stromal cell response to inflammatory stimulation.

Authors:  Andrey Ratushnyy; Danila Yakubets; Elena Andreeva; Ludmila Buravkova
Journal:  Sci Rep       Date:  2019-06-26       Impact factor: 4.379

6.  Assessment of the Immunosuppressive Potential of INF-γ Licensed Adipose Mesenchymal Stem Cells, Their Secretome and Extracellular Vesicles.

Authors:  Teresa Raquel Tavares Serejo; Amandda Évelin Silva-Carvalho; Luma Dayane de Carvalho Filiú Braga; Francisco de Assis Rocha Neves; Rinaldo Wellerson Pereira; Juliana Lott de Carvalho; Felipe Saldanha-Araujo
Journal:  Cells       Date:  2019-01-05       Impact factor: 6.600

Review 7.  Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies.

Authors:  Nádia de Cássia Noronha; Amanda Mizukami; Carolina Caliári-Oliveira; Juçara Gastaldi Cominal; José Lucas M Rocha; Dimas Tadeu Covas; Kamilla Swiech; Kelen C R Malmegrim
Journal:  Stem Cell Res Ther       Date:  2019-05-02       Impact factor: 6.832

8.  TZAP plays an inhibitory role in the self-renewal of porcine mesenchymal stromal cells and is implicated the regulation of premature senescence via the p53 pathway.

Authors:  Ya-Nan Bie; Peng Gu; Yu-Ting Chen; Xiao-Xu Zhou; Yu-Guang Tian; Qin Yang; Hai-Yan Li; Xia Lin; Yan-Hong Guan; Tao-Yan Lin; Xun Lu; Hong-Fen Shen; Ting-Xiao Fang; Yu-Min Liu; Dong Xiao; Wei-Wang Gu
Journal:  J Transl Med       Date:  2019-03-07       Impact factor: 5.531

9.  Osteoinductive Material to Fine-Tune Paracrine Crosstalk of Mesenchymal Stem Cells With Endothelial Cells and Osteoblasts.

Authors:  Hassan Rammal; Laura Entz; Marie Dubus; Aurélie Moniot; Nicolae B Bercu; Johan Sergheraert; Sophie C Gangloff; Cédric Mauprivez; Halima Kerdjoudj
Journal:  Front Bioeng Biotechnol       Date:  2019-10-09

Review 10.  Autologous cell therapy in diabetes‑associated critical limb ischemia: From basic studies to clinical outcomes (Review).

Authors:  Alessandra Magenta; Maria Cristina Florio; Massimo Ruggeri; Sergio Furgiuele
Journal:  Int J Mol Med       Date:  2021-07-19       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.